Evidence map›Paper›PMID 40940988›Full record

ArticleCancers2025

Integrated Nanosecond Pulse Irreversible Electroporation (INSPIRE): Impact of Exposed Electrode Length on Ablation Geometry in an In Vivo Liver Model.

Jordan A Fong, Logan Reeg, Jewels Darrow, Robert H Williamson, Anna Riordan, Alexia K Cash, Max Beecroft, Callie A Fogle, Kyle G Mathews, Nathan C Nelson and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jordan A FongGradient Medical Inc., Raleigh, NC 27607, USA.ORCID 0009-0000-1503-8237
Logan ReegCollege of Agriculture and Life Sciences, North Carolina State University, Raleigh, NC 27695, USA.
Jewels DarrowCollege of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.
Robert H WilliamsonLampe Joint Department of Biomedical Engineering, North Carolina State University, Raleigh, NC 27695, USA.ORCID 0000-0001-8087-4397
Anna RiordanLampe Joint Department of Biomedical Engineering, North Carolina State University, Raleigh, NC 27695, USA.
Alexia K CashLampe Joint Department of Biomedical Engineering, North Carolina State University, Raleigh, NC 27695, USA.
Max BeecroftCollege of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.
Callie A FogleCollege of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.
Kyle G MathewsCollege of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.
Nathan C NelsonCollege of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.
Alina C IugaDepartment of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
David A GerberDepartment of Surgery, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.ORCID 0000-0002-7972-5228
Michael B SanoCollege of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.

Funding

Academic-Industrial Partnership to Develop Clinical Tools for Algorithmic Irreversible Electroporation of Inoperable TumorsR01CA272550 · NCI · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI SANO, MICHAEL BENJAMIN · 2022 to 2025
$2.8M
Development of an INSPIRE System for the Treatment of Inoperable Liver TumorsR01CA276232 · NCI · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Michael Benjamin Sano · 2023 to 2026
$2.3M
Commercialization of Algorithmic Non-thermal Ablation Technology for the Treatment of Inoperable TumorsR42CA275587 · NCI · GRADIENT MEDICAL, INC. · PI Jordan Fong, Michael Benjamin Sano · 2025 to 2026
$2.3M
Feasibility of a Multi-Phase Algorithmic Non-Thermal Ablation Technology for the Treatment of Inoperable TumorsR41CA275587 · NCI · GRADIENT MEDICAL, INC. · PI FONG, JORDAN · 2022 to 2022
$260k
NCI NIH HHS R01 CA272550NCI NIH HHS R01 CA276232NCI NIH HHS R41 CA275587NCI NIH HHS R42 CA275587NIH HHS 1R01CA272550-22NIH HHS 1R01CA275587-25NIH HHS 1R01CA276232-23
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

focal ablationinoperable tumorsINSPIREIREpulsed field ablation

Identifiers

PMID40940988
PMCPMC12428063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.